Stay updated on Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Sign up to get notified when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.

Latest updates to the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be an internal version update and does not modify study data or user-facing features.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2. Removed the older notices, including the government funding lapse message and the Revision: v3.4.1 reference.SummaryDifference0.4%

- Check44 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status, with links for updated operating information (cc.nih.gov and opm.gov). Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check51 days agoChange DetectedAdded a glossary toggle and minor UI/label/version text updates (including capitalization and QC-related fields); these do not alter study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page now shows Revision: v3.3.4 and no longer lists Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.